# US 2024/0201166 A1 · Diagnosis and treatment of congestive colon failure (ccf) > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2024/0201166 A1 - Document ID: US20240201166A1 - Status: Published application - Kind: A1 - Application number: 18/286,364 - Filed: 2022-04-11 - Published: 2024-06-20 - Earliest claimed: 2021-04-11 - Inventors: Vikas Khurana - Web page: https://patentgrep.com/patent/US20240201166A1 ## CPC - A01M 1/023: {Attracting insects by the simulation of a living being, i.e. emission of carbon dioxide, heat, sound waves or vibrations} - G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems - A01M 1/026: {combined with devices for monitoring insect presence, e.g. termites (bait stations A01M1/2005; detecting other animals in a given area A01M31/002)} - A01M 1/106: {for flying insects} - A01M 13/003: {Enclosures for fumigation, e.g. containers, bags or housings} - G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising - G16H 40/63: for local operation - G16H 40/67: for remote operation - G16H 50/30: for calculating health indices; for individual health risk assessment - Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change - A01M: CATCHING, TRAPPING OR SCARING OF ANIMALS (appliances for catching swarms or drone-catching A01K57/00; fishing A01K69/00 - {A01K99/00}; biocides, pest repellants or attractants A01N); APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS - G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA - Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE ## Abstract A method of treatment for congestive colon failure (CCF) including evaluating an origin of a lipase and/or an amylase from a biological fluid sample from the subject, optionally analyzing a level of the lipase and/or an amylase from the biological fluid sample from the subject, optionally imaging a colon and a pancreas of the subject and providing laxatives, an anti-fungal composition, fat, a composition selected from a group comprising glucosamine, methylsulfonylmethane (MSM) rhamnan sulfate, Sulodexide, Rosuvastatin, Metformin, Hydrocortisone, Antithrombin, Etanercept, Heparin, Albumin, Fresh frozen plasma (FFP), Poloxamer-188, vitamins, trace elements, a locally acting vasodilator, anaerobic microbial culture, pickled fruits, pickled vegetables, preserved meat, and fermented juices or a combination thereof based upon results of the first three steps. ## Claims ### Claim 1 A method (100) of treatment for congestive colon failure (CCF) in a subject, the method comprises: a. evaluating (102) an origin of a lipase and/or an amylase from a biological fluid sample from the subject; b. optionally analyzing (104) a level of the lipase and/or an amylase from the biological fluid sample from the subject; c. optionally imaging (106) a colon and a pancreas of the subject; and d. providing (108) laxatives, an anti-fungal composition, fat, a composition selected from a group comprising glucosamine, methylsulfonylmethane (MSM) rhamnan sulfate, Sulodexide, Rosuvastatin, Metformin, Hydrocortisone, Antithrombin, Etanercept, Heparin, Albumin, Fresh frozen plasma (FFP), Poloxamer-188, vitamins, trace elements, a locally acting vasodilator, anaerobic microbial culture, pickled fruits, pickled vegetables, preserved meat, and fermented juices or a combination thereof based upon results of step a and optionally from steps b to c. ### Claim 2 (depends on 1) The method (100) of claim 1, wherein origin of the lipase and/or amylase is evaluated by the way of analyzing biomarkers related to lipase and/or amylase. ### Claim 3 (depends on 1) The method (100) of claim 1, wherein imaging is done by the way of magnetic resonance imaging (MRI), X-Ray, CT-scan, ultrasound, thermal imaging, nuclear imaging, physical exam, or a combination thereof. ### Claim 4 (depends on 1) The method (100) of claim 1, wherein the fat is selected from a group comprising non-absorbable fats, wax esters, and fat from butter fish, or a combination thereof. ### Claim 5 (depends on 1) The method (100) of claim 1, further comprises alternating between fiber and fiber free diet wherein fiber diet comprises of dietary and supplemental fiber. ### Claim 6 A kit to diagnose congestive colon failure (CCF), the kit comprises: a. at least a first reagent to identify a fungal species; b. at least a second reagent to identify fungal enzymes; and c. a test strip made of membrane adhesively attached to a solid base with the first and second reagents immobilized on it. ### Claim 7 A method (200) to differentiate between congestive colon failure and pancreatitis in a subject, the method comprises: a. evaluating (202) an origin of a lipase from a bodily fluid of the subject; b. imaging (204) a pancreas and a colon; and c. differentiating (206) between pancreatitis and congestive colon failure based on steps a and b. ### Claim 8 A method (300) to detect congestive colon failure in a subject, the method comprising: a. Administering (302) a set of sensors in the subject through the subject's mouth; b. Tracking (304) a movement of the set of sensors through a Gastro-intestinal tract of the subject; c. mapping (306) the movement of each sensor over time to compile a composite map of a movement of stool over time; and d. detecting (308) congestive colon failure based on the composite map. ### Claim 9 (depends on 8) The method (300) of claim 8, wherein the stool flow overtime is tracked using a set of Radio Frequency Identification (RFID) sensors. ### Claim 10 (depends on 8) The method (300) of claim 8, wherein the Radio Frequency Identification sensors are hygroscopic and provide real-time information. ### Claim 11 A toilet system (400) comprises: a. an input unit (402) configured to detect a set of attributes selected from a group comprising smell, consistency, texture, color, flow, and temperature associated with a human waste and generate a first signal based on the detected set of attributes; b. processing circuitry (404) coupled with the input unit (402), and configured to: (i) receive the first signal from the input unit (402); (ii) compare the first signal with provided input parameters to determine an intestinal health of the subject; (iii) determine a gastro-intestinal health of a subject by differentiating Congestive Colon Failure from pancreatic and colon-associated diseases; and c. an output unit (406) coupled with the processing circuitry (404) and configured to: (i) relay the gastro-intestinal health of the subject on an audio-visual device of the output unit (406). ### Claim 12 (depends on 11) The toilet system (400) of claim 11, wherein the input unit (402) further comprising: (i) an imaging unit (408) configured to capture images; (ii) a set of detectors (410) configured to sense temperature, texture, color, consistency, flow and a combination thereof, and (iii) an audio unit (412) configured to receive sound associated with an ejection of the human waste. ### Claim 13 (depends on 11) The toilet system (100) of claim 11, wherein the input unit (402) is adapted to receive input parameters provided by the user, such that the processing circuitry (404) compares the first signal with the provided input parameters and further determines the intestinal health of the subject. ### Claim 14 (depends on 13) The toilet system (400) of claim 13, wherein the input parameters are one of, color of feed, pH of feed, ingredients of feed, or texture of feed. ### Claim 15 (depends on 11) The toilet system (400) of claim 11, wherein the processing circuitry (404) is configured to compare the input parameter representing color of feed with the set of attributes representing the color of human waste, such that the processing circuitry (404) is adapted to differentiate Congestive Colon Failure from pancreatic and colon associated diseases. ### Claim 16 A clip device (500) for detecting and monitoring biological parameters of a subject, the clip device (500) comprising: one or more binding portions (502A-502N), each binding portion of the one or more binding portions (502A-504N) is adapted to clip on a wall of a gastrointestinal track of a subject; and a carrier portion (504) comprising: a diode (508) that is housed in the carrier portion (504), wherein upon implanting the clip device (500) in the gastrointestinal track, the diode (508) is adapted to release from the carrier portion (504), and further adapted to detect signals representing one or more biological condition of the subject. ### Claim 17 (depends on 16) The clip device (500) of claim 16, wherein the clip device (500) is inserted into the gastrointestinal track of the subject by way of an endoscope. ### Claim 18 (depends on 16) The clip device (500) of claim 16, wherein the diode (508) is adapted to communicate with a processing circuitry by way of a transceiver. ### Claim 19 A method (600) of detecting Congestive Column Failure, the method comprising: inserting (602), by way of endoscopy insertion, a clip device (500) on a gastrointestinal track of a subject; implanting (604), by way of one or more binding portions (502A and 502B), the clip device (500) on walls of the gastrointestinal track of the subject; releasing (606), upon implanting, diode (508) from a carrier portion (504) of the clip device (500); detecting (608), by way of the diode (508), signals representing one or more biological parameters associated with the gastrointestinal track of the subject; receiving (610), by way of processing circuitry, the detected signals from the diodes (508); comparing (612), by way of the processing circuitry, the received detected signals with prestored biological parameters; and analyzing (614), by way of the processing circuitry, the compared data to determine a biological condition of the subject.